Abstract: Disclosed herein are compositions and methods for treating subjects for pain with opioids while reducing or inhibiting their risk of opioid addiction.

Abstract: A screening assembly 10 includes at least one rail 14 to be secured to a support member of a screening machine to lie parallel to, and intermediate, side members of the screening machine. At least one retaining formation 18 stands proud of an operatively upper surface of each rail 14. The assembly includes a plurality of screening modules 12. Each screening module 12 comprises a supporting structure 64 and a removable screening element 66. The supporting structure 64 has an end supported on the rail 14 so that a pair of supporting structures 64 lie in end-to-end abutting relationship with the abutting ends, in use, overlying the rail 12 and defining a receiving formation through which the retaining formation 18 protrudes to project beyond the receiving formation into a recessed region defined by the abutting ends of the pair of supporting structures 64.

Abstract: A screening module retaining member 10 includes a body member 12 defining a passage 16. A retaining element 14 is displaceably arranged in the passage 16. The retaining element 14 is displaceable between a first, non-retaining position in which the retaining member is accessible from a first end of the body member 12 and a second, retaining position in which the retaining element 14 is received within the passage 16 and acts on at least a part 20 of the body member 12 for retaining the body member 12 in position relative to a component of a screen deck. A locating arrangement 22 is associated with the first end of the body member 12 for locating a screening module relative to the screen deck and for inhibiting lateral movement of the screening module relative to the body member 12.

Abstract: A screening module for a screening assembly includes a panel member having a periphery defined by a pair of opposed, parallel sides and a pair of opposed parallel ends. A mounting formation is arranged about at least a part of the periphery of the panel member for mounting the panel member on an underlying frame. A plurality of discrete aperture arrays are defined in a surface of the body member. A skirt portion circumscribes each aperture array, each skirt portion depending from a lower surface of the panel member. A reinforcing arrangement is arranged beneath each aperture array, the reinforcing arrangement being bounded by its associated skirt portion.

Abstract: A well tool is adapted to couple to at least one of a wireline service tool and a tubing string and has an adapter component engaging portion adapted to couple to an adapter component. At least a first and a second interchangeable adapter components are operable to couple to the adapter component engaging portion. The first adapter component is adapted to perform a first function and the second adapter component is adapted to perform a second function.

Abstract: A screening assembly support frame includes a body member defining a longitudinal axis. The body member has a pair of parallel, spaced elongate support members with a spacer arrangement extending between the support members. An engaging formation, for engaging a screen panel of the screening assembly to be supported by the body member, is carried on each support member with the body member and the engaging formations being symmetrical about the longitudinal axis.

Abstract: An apparatus (110) and method for treating an interval of a wellbore comprises an outer tubular (112) disposed within the wellbore. A sand control screen (118) is disposed within the outer tubular (112). A treatment fluid passageway (144) is formed between the sand control screen (118) and outer tubular (112). In addition, a production pathway (130) is formed between the sand control screen (118) and outer tubular (112). When the apparatus (110) is in an operable position, the region between the outer tubular (112) and the wellbore serves as a primary path for delivery of a treatment fluid, the production pathway (130) serves as a secondary path for delivery of the treatment fluid if the primary path becomes blocked and the treatment fluid passageway (144) serves as a tertiary path for delivery of the treatment fluid if the primary and secondary paths become blocked.